SCHEMBL3363232

SCHEMBL3363232

CS(=O)(=O)Nc1cccc(CSc2nc(N)c(C#N)c(-c3ccccc3)c2C#N)c1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 14/20 0.85
RET P07949 1/20 0.55
ADORA2A P29274 5/20 0.54
HSP90AA1 P07900 1/20 0.52
HSP90AB1 P08238 1/20 0.52
MEN1 O00255 3/20 0.51
ALDH1A1 P00352 3/20 0.51
KMT2A Q03164 3/20 0.51
ADORA2B P29275 3/20 0.51
ALOX15 P16050 2/20 0.51
ADORA3 P0DMS8 2/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPT P10636 2/20 0.51
HPGD P15428 2/20 0.51
HTT P42858 2/20 0.51
TP53 P04637 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
USP2 O75604 1/20 0.50
HSD17B10 Q99714 1/20 0.50
PDE5A O76074 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343650 0.92 ADORA1 (1.00) ADORA1RETADORA2AMEN1ALDH1A1
SCHEMBL3329013 0.89 ADORA1 (0.79) ADORA1ADORA2AMEN1ALDH1A1KMT2A
SCHEMBL3345477 0.88 ADORA1 (1.00) ADORA1RETADORA2AMEN1ALDH1A1
SCHEMBL3327818 0.87 ADORA1 (0.76) ADORA1MEN1ALDH1A1KMT2AADORA2B
SCHEMBL3364036 0.82 ADORA1 (0.69) ADORA1RETADORA2AMEN1ALDH1A1
SCHEMBL13913676 0.81 RET (0.78) ADORA1RETADORA2AMEN1ALDH1A1
SCHEMBL13914380 0.81 ADORA1 (0.72) ADORA1RETADORA2AMEN1ALDH1A1
SCHEMBL10148609 0.80 ADORA1 (0.61) ADORA1ADORA2AMEN1ALDH1A1KMT2A
SCHEMBL245416 0.79 ADORA1 (0.86) ADORA1RETADORA2AADORA2BADORA3
SCHEMBL244002 0.79 ADORA1 (0.79) ADORA1ADORA2AADORA2BADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160130230-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-05-12 US disclosed
US-9187428-B2 Substituted dicyanopyridines and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-11-17 US disclosed
US-20130210795-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-08-15 US disclosed
WO-2012000945-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210795-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF QDPR, DPYD, DDC ADORA1 3010/4885RET 2424/4885ADORA2A 3158/4885
US-20160130230-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF QDPR, DPYD, DDC ADORA1 3010/4885RET 2424/4885ADORA2A 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.